Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0.05Sales per Share
VS
Market
Sector
Industry
History
$ 2.41Close
$ 2 - $ 2.7 52-Week Range
Ticker Information
Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQORAMED PHARMACEUTICALS INC - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ORMP - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 2M | 1 | 41.74M | $ 0.05 |
| 3/31/2025 | $ 2M | 1 | 41.23M | $ 0.05 |
| 12/31/2024 | $ 0 | 1 | 40.83M | $ 0 |
| 9/30/2024 | $ 0 | 1 | 40.9M | $ 0 |
| 6/30/2024 | $ 0 | 1 | 40.96M | $ 0 |
| 3/31/2024 | $ 674K | 1 | 40.84M | $ 0.02 |
| 12/31/2023 | $ 1.34M | 1 | 40.32M | $ 0.03 |
| 9/30/2023 | $ 2.02M | 1 | 40.45M | $ 0.05 |
| 6/30/2023 | $ 2.7M | 1 | 40.23M | $ 0.07 |
| 3/31/2023 | $ 2.7M | 1 | 40.04M | $ 0.07 |
Key Performance Insights, Last 5 Years
- ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) SPS stands at $ 0.13.
- Over the past 5 years, ORAMED PHARMACEUTICALS INC's average SPS has been $ 0.06.
- The median SPS for ORAMED PHARMACEUTICALS INC during this period was $ 0.07
- ORAMED PHARMACEUTICALS INC reached its highest SPS over the past 5 years at $ 0.13.
- The lowest SPS recorded by ORAMED PHARMACEUTICALS INC in the same timeframe $ 0
ORAMED PHARMACEUTICALS INC's SPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SPS Benchmarks
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for ORAMED PHARMACEUTICALS INC is calculated as follows: Revenues [ $ 2.71M ] / (Shares WA [ 20.53M ] * Share Factor [ 1 ])
(=) SPS [ $ 0.13 ] ORMP - Sales per Share, Last 5 years
$ 0
Minimum
Jun 30, 2024
$ 0.13
Maximum
Sep 30, 2020
$ 0.06
Average
$ 0.07
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.54 with a standard deviation of $ 13.61.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.63K |
|---|---|
| min | $ -18.02 |
| max | $ 54.8 |
| average | $ 11.54 |
| median | $ 5.88 |
| std | $ 13.61 |